PubMed HealthSearch

PubMed · 2698705

[Congestive heart insufficiency. Evaluation using isotopic methods].

Abstract

Radioisotopic cardiac studies became, on the last decade, one of the more useful non-invasive methods for the diagnostic evaluation and follow-up of patients with heart disease. Such a contribution of nuclear cardiology is specially noticeable on ischemic heart disease: radionuclide angiography (RNA) allows quantification of left and right ventricular dysfunction, and therefore stands as an ideal technique for the prognostic approach of congestive heart failure. As to diagnosis, RNA is useful in the analysis of regional wall motion abnormalities of ischemic heart disease and detection of ventricular aneurysms. Clinical examples are given of these specific situations. In dilated cardiomyopathies RNA gives not only a measure of ventricular dysfunction, but also a diagnostic information, often definitive, of the diffuse involvement of all left ventricle, and commonly of the right ventricle. Ischemic heart disease, on the other hand, displays different degrees of segmental wall motion impairment together with areas of normal contractility. These aspects are documented with cases of our Registry. Also discussed is the inotropic stimulation technique for the evaluation of the functional reserve of left ventricle in patients with severe rest L.V. dysfunction. Focus is given to the clinical value of isotopic studies for the quantification of valvular regurgitations and pre-operative serial studies in order to define an optimum surgical timing. An attempt is done to grade the practical importance of the different exams of Nuclear Cardiology on the diagnostic and prognostic evaluation on heart disease patients, with a cost benefit relation perspective and comparing with other methods, classic of recent ones, available for the management of patients with heart failure.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R Ferreira, M E de Sá, J R Rebelo, A Nogueira. 1989. [Congestive heart insufficiency. Evaluation using isotopic methods].. https://pubmed.ncbi.nlm.nih.gov/2698705/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The bidirectional genetic causality between immunocyte phenotypes and dilated cardiomyopathy: A bidirectional Mendelian randomization study.

The association between immunocyte phenotypes and dilated cardiomyopathy (DCM) has been explored, however the exact pathogenesis of the relationship between immune cells and DCM is unclear. This bidirectional two-sample Mendelian randomization (MR) research aims to further validate the causal link between 731 immunocyte phenotypes and DCM. Summary statistics from a genome-wide association study data of individuals with European ancestry were utilized, including 1444 DCM cases and 353,937 controls, as well as 3757 European adults for the 731 immunocyte phenotypes. Causal effects were estimated using inverse variance weighted, MR-Egger regression, weight median estimator, weighted mode, and simple mode. Sensitivity analysis was conducted to confirm data robustness and feasibility. Based on the inverse variance weighted findings, 14 immunocyte phenotypes were risk factors for DCM (P&#x2005;<&#x2005;.05, odds ratio [OR]&#x2005;>&#x2005;1), while 15 immunocyte phenotypes exhibited a protective effect on DCM (P&#x2005;<&#x2005;.05, OR&#x2005;<&#x2005;1). The results of reverse MR analysis suggested evidence that DCM occurrence might elevate the levels of 17 immunocyte phenotypes (P&#x2005;<&#x2005;.05, OR&#x2005;>&#x2005;1) and decrease the levels of 9 immunocyte phenotypes (P&#x2005;<&#x2005;.05, OR&#x2005;<&#x2005;1). Our research indicated that CD28 on secreting regulatory T cell could mitigate the occurrence of DCM, and reciprocally, the progression of DCM could reduce the level of CD28 on secreting regulatory T cell. This study confirmed the bidirectional genetic predictive relationship between immunocyte phenotypes and DCM, underscoring the complex interplay between DCM and the immune system.

Cardiomyopathy, Dilated

The clinical course of idiopathic dilated cardiomyopathy. A population-based study.

OBJECTIVE: To describe the prognosis of individuals with idiopathic dilated cardiomyopathy in a population-based sample and to compare this with the prognosis of patients in a previous referral center case series of idiopathic dilated cardiomyopathy. DESIGN: Cohort study. SETTING: Population-based in Olmsted County, Minnesota. PATIENTS: Forty residents of Olmsted County, Minnesota with idiopathic dilated cardiomyopathy initially diagnosed between 1975 and 1984 who were followed through 1 July 1989 and 104 patients from a Mayo Clinic referral case series from 1960 to 1973. MEASUREMENTS: Survival for the population-based cohort at 1 year and 5 years. RESULTS: Survival at 1 year differed dramatically between the population-based cohort and the referral case series at 1 year (95% compared with 69%, respectively) and at 5 years (80% compared with 36%, respectively) (P less than 0.001). Long-term survival for the population-based cohort was nonetheless impaired when compared with an age- and sex-matched cohort, that is, the 1980 Minnesota white population (8-year survival: observed, 58% compared with expected, 83%; P less than 0.001). Among community patients, older age (adjusted Cox model hazard ratio for 10-year increase in age, 1.59; 95% CI, 1.08 to 2.35) and lower left ventricular ejection fraction (adjusted hazard ratio for 10% decrease, 1.90; CI, 1.04 to 3.50) were independently associated with impaired survival. CONCLUSIONS: These population-based data challenge the clinical perception of the clinical course of idiopathic dilated cardiomyopathy based on referral practice prognostic studies and suggest that the clinical course of this condition may be more favorable than previously recognized.

Cardiomyopathy, Dilated